The Trusts is seeking a reliable, cost effective and value for money for the Provision of Autologous Cell Salvage Devices and Consumables. Tenderers must comply with the UK Medical Devices Directive.

The Royal Brompton and Harefield NHS Foundation Trust — our 2 hospitals — (Royal Brompton and Harefield) have prestigious histories as independent institutions specialising in the treatment and diagnosis of heart and lung conditions. Excelling in specialist patient care since 1843.

More than 2 500 people work across both sites, and each member of the team is dedicated to providing specialist, cutting-edge care. Alongside day-to-day care, our specialists conduct invaluable research. From this, we publish findings and make evidence-based decisions to ensure we’re offering the best care to today’s patients and future generations.

The Trusts is seeking a reliable, cost effective and value for money for the Provision of Autologous Cell Salvage Devices and Consumables.

The Procurement documents are published on the ProContract portal which can be accessed through the weblink: www.lppsourcing.org

This project is identified on the ProContract portal by the title: provision of autologous cell salvage devices and consumables.